A phase II trial of the DNA methyl transferase inhibitor, SGI-110 (guadecitabine), in children and adults with wild type GIST, pheochromocytoma and paraganglioma associated with succinate dehydrogenase deficiency and HLRCC-associated kidney cancer.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. TPS2608-TPS2608 ◽  
Author(s):  
Jaydira Del Rivero ◽  
Fernanda Irene Arnaldez ◽  
Ramaprasad Srinivasan ◽  
Melissa Spencer ◽  
Seth M. Steinberg ◽  
...  
Keyword(s):  
Succinate Dehydrogenase ◽  
Kidney Cancer ◽  
Phase Ii ◽  
Dehydrogenase Deficiency ◽  
Phase Ii Trial ◽  
Wild Type ◽  
Methyl Transferase ◽  
Succinate Dehydrogenase Deficiency

Succinate dehydrogenase deficiency in human

2005 ◽  
Vol 62 (19-20) ◽  
pp. 2317-2324 ◽  
Author(s):  
J.-J. Brière ◽  
J. Favier ◽  
V. El. Ghouzzi ◽  
F. Djouadi ◽  
P. Bénit ◽  
...  
Keyword(s):  
Succinate Dehydrogenase ◽  
Dehydrogenase Deficiency ◽  
Succinate Dehydrogenase Deficiency

scholarly journals Succinate Dehydrogenase Deficiency in a Child with Bilateral Renal Cell Carcinoma

2017 ◽  
Vol 26 ◽  
pp. 18-21
Author(s):  
Tanya Marié Schickerling ◽  
Kamusisi Chinyundo ◽  
Simon Nayler ◽  
Jerome Alexander Loveland ◽  
Alan Randall Anderson
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Succinate Dehydrogenase ◽  
Renal Cell ◽  
Dehydrogenase Deficiency ◽  
Bilateral Renal Cell Carcinoma ◽  
Succinate Dehydrogenase Deficiency

scholarly journals Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer

2022 ◽  
Author(s):  
Raquibul Hannan ◽  
Michael Christensen ◽  
Hans Hammers ◽  
Alana Christie ◽  
Brendan Paulman ◽  
...  
Keyword(s):  
Kidney Cancer ◽  
Phase Ii ◽  
Phase Ii Trial

The 3PAs syndrome and succinate dehydrogenase deficiency in pituitary tumors

2021 ◽  
pp. 127-155
Author(s):  
Paraskevi Xekouki ◽  
Vasiliki Daraki ◽  
Grigoria Betsi ◽  
Maria Chrysoulaki ◽  
Maria Sfakiotaki ◽  
...  
Keyword(s):  
Succinate Dehydrogenase ◽  
Dehydrogenase Deficiency ◽  
Pituitary Tumors ◽  
Succinate Dehydrogenase Deficiency

scholarly journals Rapamycin as a potential treatment for succinate dehydrogenase deficiency

Heliyon ◽  
2019 ◽  
Vol 5 (2) ◽  
pp. e01217 ◽  
Author(s):  
Frances Fan ◽  
Rheba Sam ◽  
Emma Ryan ◽  
Katherine Alvarado ◽  
Eugenia Villa-Cuesta
Keyword(s):  
Succinate Dehydrogenase ◽  
Dehydrogenase Deficiency ◽  
Potential Treatment ◽  
Succinate Dehydrogenase Deficiency

scholarly journals Phase II trial of Panitumumab for patients with KRAS exon2 wild type mCRC after progression on Cetuximab: HGCSG1101

2017 ◽  
Vol 28 ◽  
pp. ix86
Author(s):  
Ayumu Hosokawa ◽  
Satoshi Yuki ◽  
Kazuaki Harada ◽  
Yasushi Tsuji ◽  
Kazuteru Hatanaka ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Wild Type
Sign in / Sign up

Export Citation Format

Share Document